Correction, Sept. 9: The list price of Zepbound has been revised from an earlier version of this article. Eli Lilly’s decision to sell its obesity drug Zepbound directly to patients for $499 per month ...

Direct-to-consumer has become luxury’s control center. What first gained traction as a higher-margin alternative to wholesale in the mid-2010s became a necessity during the pandemic. In the years ...